Journal Article > ResearchFull Text
Genome Biol. 2017 January 19; Volume 18 (Issue 1); DOI:10.1186/s13059-016-1137-3
Liu X, Speranza E, Munoz-Fontela C, Haldenby S, Rickett NY, et al.
Genome Biol. 2017 January 19; Volume 18 (Issue 1); DOI:10.1186/s13059-016-1137-3
In 2014, Western Africa experienced an unanticipated explosion of Ebola virus infections. What distinguishes fatal from non-fatal outcomes remains largely unknown, yet is key to optimising personalised treatment strategies. We used transcriptome data for peripheral blood taken from infected and convalescent recovering patients to identify early stage host factors that are associated with acute illness and those that differentiate patient survival from fatality.